TD Cowen analyst Jason Gabelman lowered the firm’s price target on Calumet Specialty Products to $18 from $20 and keeps a Buy rating on the shares. The firm said its equity jumped on earnings with net debt falling more than forecast. MRL’s first clean quarter generated positive EBITDA at trough conditions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLMT: